Piscataway, NJ, United States of America

Amos E Enabosi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Starch and Chemical Investment Holding Corporation. Active years: 2003.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amos E. Enabosi: Innovator in Pharmaceutical Excipients

Introduction

Amos E. Enabosi is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceutical excipients, particularly through his innovative work on polysaccharide materials. His expertise and inventions have had a meaningful impact on the development of tablet formulations.

Latest Patents

Amos E. Enabosi holds a patent for a "Polysaccharide material for direct compression." This invention relates to a method of using compressible polysaccharides with a tap density of less than 0.4 g/ml as a filler and binder for tablets prepared by direct compression. The patent details excipient blends that include these polysaccharides, methods of tableting active ingredients from these blends, and the resulting tablets. Notably, the invention emphasizes the use of low-density starches as binders, which enhance the moisture resistance of the starch-based excipient composition.

Career Highlights

Amos E. Enabosi is associated with National Starch and Chemical Investment Holding Corporation, where he has applied his innovative ideas to advance the field of pharmaceutical excipients. His work has been instrumental in improving the efficiency and effectiveness of tablet formulations.

Collaborations

Throughout his career, Amos has collaborated with notable colleagues, including Eric Weisser and Judith K. Whaley. These collaborations have contributed to the development of innovative solutions in the pharmaceutical industry.

Conclusion

Amos E. Enabosi's contributions to the field of pharmaceutical excipients through his patent on polysaccharide materials demonstrate his commitment to innovation. His work continues to influence the development of effective tablet formulations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…